Last updated on March 2018

An Open-Label, Pilot Pharmacokinetic Study of INCB018424 Phosphate Cream in Pediatric Subjects With Atopic Dermatitis


Brief description of study

An Open-Label, Pilot Pharmacokinetic Study of INCB018424 Phosphate Cream in Pediatric Subjects With Atopic Dermatitis

Detailed Study Description

The purpose of this study is to evaluate the safety and tolerability of topical INCB018424 cream applied to pediatric subjects (≥ 12 to 17 years) with atopic dermatitis (AD).

Clinical Study Identifier: TX153343

Contact Investigators or Research Sites near you

Start Over

National Jewish Center

National Jewish Center
Denver, CO USA
  Connect »

Rady Children's Hospital

Rady Children's Hospital
San Diego, CA USA
  Connect »

Northwestern University

Northwestern University
Chicago, IL USA
  Connect »